FDA Inspection 1224290 — NATCO PHARMA LTD
The FDA completed an inspection of NATCO PHARMA LTD on Nov 1, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 1, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)